Advagene Biopharma Co (ROCO:6709) Price-to-Tangible-Book : 14.57 (As of May. 26, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Advagene Biopharma Co Price-to-Tangible-Book?

As of today (2024-05-26), Advagene Biopharma Co's share price is NT$23.60. Advagene Biopharma Co's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was NT$1.62. Hence, Advagene Biopharma Co's Price to Tangible Book Ratio of today is 14.57.

The historical rank and industry rank for Advagene Biopharma Co's Price-to-Tangible-Book or its related term are showing as below:

ROCO:6709' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.47 Med: 7.5 Max: 12.16
Current: 9.01

During the past 8 years, Advagene Biopharma Co's highest Price to Tangible Book Ratio was 12.16. The lowest was 3.47. And the median was 7.50.

ROCO:6709's Price-to-Tangible-Book is ranked worse than
85.34% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs ROCO:6709: 9.01

A closely related ratio is called PB Ratio. As of today, Advagene Biopharma Co's share price is NT$23.60. Advagene Biopharma Co's Book Value per Sharefor the quarter that ended in Jun. 2023 was NT$1.71. Hence, Advagene Biopharma Co's P/B Ratio of today is 13.80.

Advagene Biopharma Co Price-to-Tangible-Book Historical Data

The historical data trend for Advagene Biopharma Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advagene Biopharma Co Price-to-Tangible-Book Chart

Advagene Biopharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.51

5.15

9.85

12.16

9.99

Advagene Biopharma Co Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial										9.85	9.89	12.16	19.27	9.99

Competitive Comparison of Advagene Biopharma Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Advagene Biopharma Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advagene Biopharma Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advagene Biopharma Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Advagene Biopharma Co's Price-to-Tangible-Book falls into.

Advagene Biopharma Co Price-to-Tangible-Book Calculation

Advagene Biopharma Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	23.60	/	1.62
	=	14.57

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Advagene Biopharma Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Advagene Biopharma Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Advagene Biopharma Co (ROCO:6709) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114

Website

http://www.advagene.com.tw

Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.

Advagene Biopharma Co (ROCO:6709) Headlines

No Headlines